Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adma Biologics (NQ: ADMA )

19.50 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Adma Biologics

< Previous 1 2 3 4 5 Next >
Peeling Back The Layers: Exploring ADMA Biologics Through Analyst Insights
Via Benzinga
Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans
Neurocrine Biosciences has long been known for its blockbuster drug Ingrezza. It's diversifying, developing multiple drugs in related areas. 
Via Investor's Business Daily
Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade
On Wednesday, Madrigal Pharmaceuticals stock earned an upgrade to its Relative Strength (RS) Rating, from 74 to 90. 
Via Investor's Business Daily
Krystal Biotech Stock Sees RS Rating Jump To 91
On Tuesday, Krystal Biotech stock cleared a key technical benchmark, seeing its Relative Strength Rating jump to 91 from 88. 
Via Investor's Business Daily
Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday
Via Benzinga
ADMA Biologics Analysts Increase Their Forecasts After Upbeat Results
Via Benzinga
A Closer Look at 6 Analyst Recommendations For ADMA Biologics
Via Benzinga
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
ADMA Stock Earnings: ADMA Biologics Beats EPS, Beats Revenue for Q1 2024
ADMA stock results show that ADMA Biologics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Forecasting The Future: 4 Analyst Projections For ADMA Biologics
Via Benzinga
Recap: ADMA Biologics Q4 Earnings
Via Benzinga
Earnings Preview For ADMA Biologics
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For ADMA Biologics
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Chart Of The Day: ADMA Biologics - Hitting New Highs
100% technical buy signals 8 new highs and up 7.24% in the last month 110.10+ Weighted Alpha 
Via Talk Markets
Why Adma Biologics Stock Crushed the Market on Friday
The network of FDA-approved collection facilities continues to grow. 
Via The Motley Fool
Why Adma Biologics Was Trouncing the Market Today
The company beat analyst estimates for both revenue and profitability, and raised revenue guidance. 
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Earnings Preview: ADMA Biologics
Via Benzinga
Preview: ADMA Biologics's Earnings
Via Benzinga
Recap: ADMA Biologics Q1 Earnings
Via Benzinga
A Preview Of ADMA Biologics's Earnings
Via Benzinga
Why Shares of ADMA Biologics Are Climbing Thursday
The company, which focuses on infectious diseases, reported its second-quarter earnings on Wednesday after the markets closed. 
Via The Motley Fool
AT&T, Carvana, Northern Trust, And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded higher, with the Dow Jones gaining over 250 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50. 
Via Benzinga
ADMA Biologics, C3.ai And Other Big Stocks Moving Higher On Friday
U.S. stocks traded lower, with the Dow Jones dropping around 150 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Dow Down 150 Points; US Durable Goods Orders Drop In February
U.S. stocks traded lower this morning, with the Dow Jones dropping around 150 points on Friday. Following the market opening Friday, the Dow traded down 0.50% to 31,944.01 while the NASDAQ fell 0.52%... 
Via Benzinga
Oxford Industries, Express And 3 Stocks To Watch Heading Into Friday
With US futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
After-Hours Action: Why ADMA Biologics Shares Are Trading Higher
ADMA Biologics Inc (NASDAQ: ADMA) shares are moving higher in extended trading Thursday after the commercial biopharmaceutical company reported  
Via Benzinga
Earnings Scheduled For March 23, 2023
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.